logo
episode-header-image
Jul 2023
9m 3s

Treatments for Alzheimer’s, finally

Financial Times
About this episode

The Nasdaq Composite had its biggest one-day drop in more than four months, the winner of Thailand’s general election has been suspended from parliament, and the FT’s Clive Cookson tells us about two huge breakthroughs in the treatment of Alzheimer’s. 


Mentioned in this podcast:

Nasdaq drops more than 2% after Netflix and Tesla results disappoint

Thai election winner blocked from premiership

Eli Lilly drug shown to slow Alzheimer’s progression


The FT News Briefing is produced by Fiona Symon, Sonja Hutson and Marc Filippino. Additional help from Saffeya Ahmed, Monica Lopez, Katie McMurran, Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT’s executive producer. The FT’s global head of audio is Cheryl Brumley. The show’s theme song is by Metaphor Music. 


Read a transcript of this episode on FT.com


Hosted on Acast. See acast.com/privacy for more information.

Up next
Yesterday
JPMorgan walks into another football firestorm
Amazon reported accelerated cloud growth in the quarter to the end of June, and JPMorgan has walked into another football firestorm as it works on a plan with Fifa. Plus, Citadel bought Situational Awareness equity holdings after the hedge fund suffered steep AI losses, and DR Co ... Show More
13m 12s
Jul 30
Fed holds rates as inflation fears grow
Meta and Microsoft reported quarterly earnings as investors raised concerns about AI spending, and the US Federal Reserve held interest rates steady. The Bank of Japan is also expected to leave rates unchanged at its meeting on Friday, and UK oil and gas companies are looking awa ... Show More
12m 40s
Jul 29
The Big Tech earnings dilemma
Ukraine is shifting its long-range drone campaign to focus on critical Russian infrastructure, and Big Tech companies are facing an AI dilemma as they report quarterly earnings. Plus, Google DeepMind is leaving behind its Nobel-winning AlphaFold project for new ventures, and PwC ... Show More
12m 22s
Recommended Episodes
Nov 2022
David Cameron on the Alzheimer's Breakthrough
The former prime minister says it’s his “happiest day” as president of Alzheimer’s Research UK, after the discovery of the first drug to slow the disease.He also speaks about whether he did enough during his premiership to support those who needed dementia care.And, the BBC’s hea ... Show More
26m 52s
Apr 2023
Audio long read: Conquering Alzheimer’s — a look at the therapies of the future
Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ... Show More
17m 31s
Apr 2022
Dementia: Could lessons from Covid help find a cure?
Just before the pandemic, the government promised a 'dementia moonshot' to blast us towards a dementia cure. What happened to it?Today: former prime minister David Cameron and Sunday Times science editor Ben Spencer on Britain’s fastest growing disease, dementia.This podcast was ... Show More
30m 42s
Jun 2023
Biden Wins the Debt Deal, and AI Extinction
Elizabeth Holmes goes to prison, the Sackler family escapes liability, and Twitter's valuation drops even lower. Also, Congress votes to raise the debt ceiling, but did Speaker McCarthy get floored? Leading AI scientists and entrepreneurs warn of possible extinction. Kara and Sco ... Show More
1h 4m